Berti F, Rossoni G, Della Bella D, Trento F, Bernareggi M, Robuschi M
Department of Pharmacology, Chemotherapy and Medical Toxicology, University of Milan, Italy.
Arzneimittelforschung. 1994 Dec;44(12):1342-6.
In anaesthetized ventilated guinea-pig, acetaldehyde (CAS 75-07-0) (40-80 mg/kg i.v.) elicits a dose-dependent increase in intratracheal pressure accompanied by an increase in circulating histamine. When acetaldehyde is injected repeatedly at 15 min intervals in capsaicin-desensitized animals, it already loses its activity at the second administration (50% reduction; p < 0.01); this does not happen in control animals. This phenomenon is even more marked when acetaldehyde is given at the dose of 80 mg/kg i.v., since at the third injection both the bronchoconstriction and the increase in blood histamine are almost completely reduced to baseline values. The increase in intratracheal pressure caused by acetaldehyde (20, 40, 80 mg/kg i.v.) is associated with a dose related increase in microvascular permeability and leakage of protein-bound Evans blue in lower tracheal tissue. This event and the bronchoconstrictor response caused by acetaldehyde (40 mg/kg i.v.) are 87% and 35% inhibited, respectively, (p < 0.01) in tachykinin-depleated animals. On the contrary, thiorphan (2 mg/kg i.v.) remarkably potentiates both the rise in intratracheal pressure (110%; p < 0.01) and Evans blue extravasation (215%; p < 0.01) induced by acetaldehyde (20 mg/kg i.v.) in normal guinea-pigs. Furthermore, treatment with CP-96,345, a selective tachykinin NK1-receptor antagonist, only prevents plasma extravasation in lower tracheal tissue (82% inhibition; p < 0.01) without affecting the bronchoconstriction caused by acetaldehyde (40 mg/kg i.v.).(ABSTRACT TRUNCATED AT 250 WORDS)
在麻醉通气的豚鼠中,静脉注射乙醛(CAS 75 - 07 - 0)(40 - 80毫克/千克)会引起气管内压力呈剂量依赖性升高,并伴有循环组胺增加。当在辣椒素脱敏的动物中每隔15分钟重复注射乙醛时,在第二次给药时它就已经失去活性(降低50%;p < 0.01);而在对照动物中不会出现这种情况。当静脉注射80毫克/千克剂量的乙醛时,这种现象更为明显,因为在第三次注射时,支气管收缩和血液组胺增加几乎完全降至基线值。静脉注射乙醛(20、40、80毫克/千克)引起的气管内压力升高与气管下部组织中微血管通透性增加以及与蛋白质结合的伊文思蓝渗漏呈剂量相关。在速激肽耗竭的动物中,乙醛(40毫克/千克静脉注射)引起的这一事件和支气管收缩反应分别受到87%和35%的抑制(p < 0.01)。相反,在正常豚鼠中,硫磷酰胺(2毫克/千克静脉注射)显著增强了乙醛(20毫克/千克静脉注射)诱导的气管内压力升高(110%;p < 0.01)和伊文思蓝外渗(215%;p < 0.01)。此外,用选择性速激肽NK1受体拮抗剂CP - 96,345治疗仅能防止气管下部组织中的血浆外渗(82%抑制;p < 0.01),而不影响乙醛(40毫克/千克静脉注射)引起的支气管收缩。(摘要截短至250字)